Indraprastha Medical Corporation Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.

Profit growth above 25%EBITDA margin expansionResults View source PDF Explain this filing

INDRAMEDCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.2%Reaction day

₹441.00

prior close

₹449.15

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.2%-3.4% vs market

Hospital peers, median of 19sector-0.8%-1.4% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 1.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-1.8

15m

-2.1

30m

-3.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.2+1.2-3.4-0.8-1.4

Next day

-5.0+0.1-5.2-0.9-4.2

-4.5+0.9-5.4-1.6-2.9

-5.8+0.8-6.6-1.6-4.2

-6.7+1.4-8.2+0.8-7.6

-0.8+2.0-2.8+0.3-1.2

+0.0+2.3-2.3-0.9+0.9

15d

-3.9+5.2-9.0-0.7-3.2

-12.1+1.6-13.6-0.8-11.3

+8.0+7.7+0.4+4.5+3.6

+6.0+4.0+2.0+11.7-5.7

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 19Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) approved audited financial results for FY25 (year ended March 31, 2025) with a clean (unmodified) auditor opinion. Revenue from operations grew to Rs. 1,356.36 crore from Rs. 1,244.70 crore (~9% YoY), while profit after tax jumped to Rs. 160.99 crore from Rs. 123.96 crore (~30% YoY), driving EPS to Rs. 17.56 from Rs. 13.52. The Board recommended a dividend of Rs. 4.50 per share (45%), unchanged from last year. Operating cash flow stood at Rs. 156.75 crore, reserves strengthened to Rs. 505.01 crore, and the company confirmed it has no outstanding qualified borrowings, so it is not classified as a Large Corporate.

Likely market impact

Strong profit growth (~30%) with margin expansion and maintained dividend signals healthy operational performance, likely to be viewed positively by shareholders. Declining operating cash flow despite higher profits (due to working capital changes) is a minor watch point.